All In MedTech

FDA Clearance Tracker · P010030-S162

LifeVest Wearable Defibrillator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 30, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 30, 2023

Approved

Time to decision

206 days

Received Dec 6, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010030-S162
Device name
LifeVest Wearable Defibrillator
Applicant location
Pittsburgh, PA
Received
Dec 6, 2022
Decided
Jun 30, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P010030

Device type

Device class
Class III

Every decision under product code MVK

FDA's approval statement

As written in FDA's record.

Approval for the new generation model, LifeVest 5100, involving minor software, hardware and labeling changes.

Source documents

Other decisions for Zoll Manufacturing Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.